BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yamagiwa S, Ishikawa T, Waguri N, Sugitani S, Wakabayashi H, Ohkoshi S, Tsukishiro T, Takahashi T, Watanabe T, Terai S. Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C. World J Hepatol 2017; 9(5): 252-262 [PMID: 28261382 DOI: 10.4254/wjh.v9.i5.252]
URL: https://www.wjgnet.com/1948-5182/full/v9/i5/252.htm
Number Citing Articles
Z. M. Younossi, A. Tanaka, Y. Eguchi, L. Henry, R. Beckerman, M. Mizokami. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in JapanJournal of Viral Hepatitis 2018; 25(8): 945 doi: 10.1111/jvh.12886
Chung-Feng Huang, Ming-Lung Yu. Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developmentsExpert Opinion on Pharmacotherapy 2017; 18(17): 1867 doi: 10.1080/14656566.2017.1400010